One of biotech's most valuable startups just filed to go public. Here are 5 crucial takeaways from ...

Retrieved on: 2021-01-13 20:48:45

Tags for this article:

Click the tags to see associated articles and topics

One of biotech's most valuable startups just filed to go public. Here are 5 crucial takeaways from .... View article details on hiswai:

Excerpt

Sana Biotechnology CEO Dr. Steve Harr Juno Therapeutics ... Seattle-based Sana Biotechnology filed paperwork on Wednesday for an initial public ...

Article found on: www.businessinsider.com